News

The Lancet8d
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
Copyright: © 2022 Elsevier Ltd. All rights reserved.
The Australian23d
How entrepreneur, philanthropist and winemaker Peter Teakle’s legacy lives on
It was a crisp mid winter morning in Port Lincoln on June 29, 2024, with a salty breeze curling in from Boston Bay, when the famed Line & Label restaurant stood solemn and still. Normally a ...